OMOP CDM

In one line

The OMOP Common Data Model is a standard relational schema (person, condition_occurrence, drug_exposure, measurement…) plus standardised vocabularies, so observational data from any source becomes analysable by shared, reusable code.

The problem it solves

Observational health data is a Tower of Babel: every hospital, claims system and registry has its own schema and codes, so an analysis written for one can't run on another, and multi-site research means re-engineering everything per site. OMOP's answer: remap everyone's data into one common shape, so a study written once runs everywhere — and results are comparable.

How it works

You ETL your source (EHR, claims, registry) into OMOP's standard tables, mapping local codes to standard concepts:

• conditions → SNOMED CT
• drugs → RxNorm
• measurements → LOINC

…via the OMOP vocabulary tables. (Tools like WhiteRabbit/Rabbit-in-a-Hat plan the ETL; Usagi helps map codes.)

The payoff: the OHDSI ecosystem

Once your data is in the CDM, you inherit a whole ecosystem:

• ATLAS for visual cohort definitions.
• Validated methods libraries for incidence, prediction, and effect estimation.
• Network studies — dozens of institutions run the same analysis locally and share only results: federated evidence at global scale, no patient data leaving any site.

OMOP vs FHIR — different jobs

The clean division of labour: FHIR moves one patient's data for care; OMOP shapes millions of patients' data for research. They're complementary — FHIR at the point of care, OMOP at the analytics layer.

Where it shows up in digital health

Real-world evidence for drug safety and effectiveness; multi-country studies (OHDSI network sites span every continent, India included); and the pragmatic answer to "our data is in seventeen formats" — make OMOP the analysis layer.

Common pitfalls

• Underestimating the ETL — mapping local codes to standard concepts is the hard, careful part; quality here determines analysis validity.
• Treating OMOP as an operational store — it's for analysis, not running the clinic (that's the EHR/FHIR side).
• Skipping data-quality checks — OHDSI's DQD/Achilles tools exist because bad mappings produce confident wrong answers.

Key takeaways

• OMOP CDM = one standard schema + vocabularies for observational data — write once, run anywhere.
• ETL your source in, mapping to SNOMED/RxNorm/LOINC; quality of mapping is everything.
• Unlocks the OHDSI ecosystem (ATLAS, methods libraries, federated network studies).
• FHIR for one patient's care; OMOP for millions of patients' research.